欧州連合 - イタリア語 - EMA (European Medicines Agency)

sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 e 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.

イタリア - イタリア語 - Ministero della Salute

n&t system s.r.l. - apparecchiature per la stimolazione neuromuscolare non altrimenti classificate

イタリア - イタリア語 - Ministero della Salute

eikos s.r.l. - dispositivi non compresi nelle classi precedenti - altri

イタリア - イタリア語 - Ministero della Salute

dormisano int. s.r.l. - materassi e traverse antidecubito

イタリア - イタリア語 - Ministero della Salute

dormisano int. s.r.l. - materassi e traverse antidecubito

イタリア - イタリア語 - Ministero della Salute

mediland rusch care srl - sistemi e prodotti per immobilizzazione - altri

イタリア - イタリア語 - Ministero della Salute

mediland rusch care srl - sistemi e prodotti per immobilizzazione - altri

イタリア - イタリア語 - Ministero della Salute

boston scientific corporation - guide per apparato cardiocircolatorio - accessori

イタリア - イタリア語 - Ministero della Salute

euro sonit srl - apparecchi acustici o ausili per l'udito - altri

イタリア - イタリア語 - Ministero della Salute

invivo corporation - monitor multiparametrici trasportabili/portatili